Myocarditis associated with Covid‐19 disease: A systematic review of published case reports and case series

  title={Myocarditis associated with Covid‐19 disease: A systematic review of published case reports and case series},
  author={Sawai Singh Rathore and Gianpier Alonzo Rojas and Manush Sondhi and Suveenkrishna Pothuru and Reshma Pydi and Neeraj Kancherla and Romil Singh and Noman Khurshid Ahmed and Jil Shah and Sohaib Tousif and Unaiza Tariq Baloch and Qingqing Wen},
  journal={International Journal of Clinical Practice},
Covid‐19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS‐CoV‐2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. 

A case of fulminant myocarditis due to COVID‐19 in an adolescent patient successfully treated with venous arterial ECMO as a bridge to recovery

The clinical course of a previously healthy 12‐year‐old female who rapidly deteriorated into cardiogenic shock and arrest due to coronavirus disease 2019 induced fulminant myocarditis is described, necessitating venous‐arterial extracorporeal membrane oxygenation as a bridge to full recovery.

COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review

It is essential to demarcate COVID-19 infection and myocarditis presentations due to the heightened risk of death among patients contracting both myocardial inflammation and ARDS, with a multitude of diagnostic and treatment options available.

COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond

The incidence, potential mechanisms, blood and imaging tests that can be used to detect the disease, and a brief update on the proposed mechanisms of myocarditis in COVID-19 vaccine recipients are included.

Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?

Past literature analysis showed that MYO is an adverse event that can follow the COVID-19 immunization with mRNA vaccines in few persons, particularly young adults, adolescents, and older children, and it is generally a mild disease that should not modify the present recommendations for Immunization with the authorized CO VID-19 mRNA vaccines.

A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation

The results highlight the need to consider the possibility of post‐COVID‐19 acute TE in patients presenting with hair fall, with a history of COvid‐19 infection, in the context of CO VID‐19 pandemic.

Cardiac Complications of COVID-19 in Low-Risk Patients

The acute and chronic cardiac consequences of COVID-19 in low-risk patients are summarized, the pathophysiology behind them is explored, and new predictive factors for poor outcomes are discussed.

Case Report: Successful Treatment of a Child With COVID-19 Reinfection-Induced Fulminant Myocarditis by Cytokine-Adsorbing oXiris® Hemofilter Continuous Veno-Venous Hemofiltration and Extracorporeal Membrane Oxygenation

It is concluded that the novel highly-absorptive hemofilter CVVH and VA-ECMO may be effective treatment modalities in managing SARS-CoV-2-induced fulminant myocarditis.

Cardiac complications of COVID-19: Incidence and outcomes



Kawasaki Disease Features and Myocarditis in a Patient with COVID-19

A 10-year-old male with prolonged fever, rash, and conjunctivitis presented to the emergency department with concern for Kawasaki disease, found to have myocarditis and PCR positive for SARS-CoV-2.

SARS-CoV-2 Fulminant Myocarditis

Features of severe COVID‐19: a systematic review and meta‐analysis

Clinical and biochemical characteristics associated with the severity of the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐related disease (COVID‐19) are reviewed.

Case report of an isolated myocarditis due to COVID-19 infection in a paediatric patient

In the context of the acute CO VID-19 outbreak, screening for COVID-19 infection should be performed in children presenting with myocardial injury in an inflammatory context.

Pediatric Life-Threatening Coronavirus Disease 2019 With Myocarditis

The case of a pediatric life-threatening coronavirus disease 2019 who presented as myocarditis with heart failure is reported, possibly linked to an exaggerated inflammatory host immune response to severe acute respiratory syndrome coronav virus 2.

Peripartum cardiomyopathy in a COVID‐19‐infected woman: differential diagnosis with acute myocarditis—A case report from a Hub Institution during the COVID‐19 outbreak

Early cardiac magnetic resonance was crucial for the diagnosis of postpartum cardiomyopathy and for the exclusion of virus‐related myocarditis, allowing us to decide on a prudent and supportive clinical approach.

Acute myocarditis associated with COVID-19 infection☆

Atypical Manifestation of COVID-19-Induced Myocarditis

The case of a 39-year-old male who presented with chest pain without fever or respiratory symptoms and was found to be coronavirus disease 2019 (COVID-19) positive is presented, illustrating that CO VID-19 can present atypically and affect an isolated non-respiratory organ system.